Post-marketing Surveillance of Donepezil Hydrochloride- Investigation of the Clinical Safety and Effectiveness in Patients With Alzheimer's Disease
Phase of Trial: Phase IV
Latest Information Update: 02 Mar 2017
At a glance
- Drugs Donepezil (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Sponsors Eisai Co Ltd
- 11 Oct 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 06 Feb 2012 Company added as trial sponsor (Eisai Inc) as reported by ClinicalTrials.gov.
- 06 Feb 2012 Additional lead trial investigator (Shoya Yamakawa) identified as reported by ClinicalTrials.gov.